Rhabdomyosarcoma and Other Soft-Tissue Sarcomas

This publication has 18 references indexed in Scilit:

• Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
  Journal of Clinical Oncology, 2009
• Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: Report of the HD CWS‐96 trial
  Pediatric Blood & Cancer, 2008
• Initial Patient Characteristics Can Predict Pattern and Risk of Relapse in Localized Rhabdomyosarcoma
  Journal of Clinical Oncology, 2008
• Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: A report from the Children's Oncology Group
  Pediatric Blood & Cancer, 2008
• PET for Staging in Rhabdomyosarcoma: An Evaluation of PET as an Adjunct to Current Staging Tools
  Journal of Pediatric Hematology/Oncology, 2007
• Response to vinorelbine and low‐dose cyclophosphamide chemotherapy in two patients with desmoplastic small round cell tumor
  Pediatric Blood & Cancer, 2005
• Vinorelbine and low‐dose cyclophosphamide in the treatment of pediatric sarcomas
  Cancer, 2004
• Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
  Journal of Clinical Oncology, 2001
• The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma
  Journal of Pediatric Surgery, 1999
• Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II).
  Journal of Clinical Oncology, 1987